All Stories

  1. Use of encapsulated dexamethasone sodium phosphate (eDSP) in chronic obstructive pulmonary disease, cystic fibrosis, and inflammatory bowel disorders
  2. GAMT Deficiency: Clinical Presentation, Treatment, Diagnosis, Animal Models, Preclinical and Clinical Developments
  3. Longitudinal Evaluation of Humoral and Cellular Immunity After BNT162b2 COVID-19 Vaccination: Influence of Booster Type, Infection and Chronic Health Conditions
  4. Immunoproteasome remodeling in senescing human macrophages reveals the loss of PA28αβ capping as a hallmark of immunosenescence
  5. Redox modulation by a synthetic thiol compound reduces LPS-induced pro-inflammatory cytokine expression in macrophages via AP-1/NLRP3 axis and influences the crosstalk with endothelial cells
  6. Redox modulation via a synthetic thiol compound reshapes energy metabolism in endothelial cells and ameliorates angiogenic expression in a co-culture study with activated macrophages
  7. Red blood cells could protect miRNAs from degradation or loss thanks to Argonaute 2 binding
  8. Engineered Oxalate Decarboxylase Boosts Activity and Stability for Biological Applications
  9. Molecular Fingerprints-Based Machine Learning for Metabolic Profiling
  10. Predicting metabolic responses in genetic disorders via structural representation in machine learning
  11. Characterization of bacterial communities associated with seabed sediments in offshore and nearshore sites to improve Microbiologically Influenced Corrosion mitigation on marine infrastructures
  12. Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
  13. New findings about neuropathological outcomes in the PKU mouse throughout lifespan
  14. Biochemical Studies on Human Ornithine Aminotransferase Support a Cell-Based Enzyme Replacement Therapy in the Gyrate Atrophy of the Choroid and Retina
  15. Efficient and highly reproducible production of red blood cell-derived extracellular vesicle mimetics for the loading and delivery of RNA molecules
  16. Exploring Machine Learning for Untargeted Metabolomics Using Molecular Fingerprints
  17. CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study
  18. Development and characterization of DIA 12.3, a fully human intact anti-CEACAM1 monoclonal antibody
  19. Old and new strategies in therapy and diagnosis against fungal infections
  20. A synthetic thiol molecule releasing N-acetyl-l-cysteine and cysteamine drives early up-regulation of immunoproteasome subunits in the lymph nodes of mice infected with LP-BM5 leukemia retrovirus
  21. Drug transport by red blood cells
  22. Rapid monitoring of SARS-CoV-2 variants of concern through high-resolution melt analysis
  23. Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
  24. KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab
  25. Compatibility of Nucleobases Containing Pt(II) Complexes with Red Blood Cells for Possible Drug Delivery Applications
  26. Assessment of a new UV-C light-emitting diode–based technology for air sanitization in indoor sports environments
  27. Comparing Heterologous and Homologous COVID-19 Vaccination: A Longitudinal Study of Antibody Decay
  28. Sirtuin 6 Regulates the Activation of the ATP/Purinergic Axis in Endothelial Cells
  29. Clonal Spread of Hospital-Acquired NDM-1-Producing Klebsiella pneumoniae and Escherichia coli in an Italian Neonatal Surgery Unit: A Retrospective Study
  30. Anoxia Rapidly Induces Changes in Expression of a Large and Diverse Set of Genes in Endothelial Cells
  31. Extracellular Vesicles as New Players in Drug Delivery: A Focus on Red Blood Cells-Derived EVs
  32. AFM evaluation of a humanized recombinant antibody affecting C. auris cell wall and stability
  33. Targeting SARS‐CoV ‐2 by synthetic dual‐acting thiol compounds that inhibit Spike/ ACE2 interaction and viral protein production
  34. New human ATM variants are able to regain ATM functions in ataxia telangiectasia disease
  35. Development and in vitro characterization of a humanized scFv against fungal infections
  36. Meet the Editorial Board Member
  37. Functionalized 3D scaffolds for engineering the hematopoietic niche
  38. The host micro-RNA cfa-miR-346 is induced in canine leishmaniasis
  39. Engineering new metabolic pathways in isolated cells for the degradation of guanidinoacetic acid and simultaneous production of creatine
  40. SARS-CoV-2 RNA Detection on Environmental Surfaces in a University Setting of Central Italy
  41. Persistence of Unintegrated HIV DNA Associates With Ongoing NK Cell Activation and CD34+DNAM-1brightCXCR4+ Precursor Turnover in Vertically Infected Patients Despite Successful Antiretroviral Treatment
  42. CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML
  43. Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination
  44. Prevalence and Molecular Typing of Carbapenemase-Producing Enterobacterales among Newborn Patients in Italy
  45. External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy
  46. Airborne Microorganism Inactivation by a UV-C LED and Ionizer-Based Continuous Sanitation Air (CSA) System in Train Environments
  47. Influenza Virus Down-Modulates G6PD Expression and Activity to Induce Oxidative Stress and Promote Its Replication
  48. Multitalented Synthetic Antimicrobial Peptides and Their Antibacterial, Antifungal and Antiviral Mechanisms
  49. SPIO nanoparticles and magnetic erythrocytes as contrast agents for biomedical and diagnostic applications
  50. Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS–FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity
  51. Phenotype Screening of an Azole-bisindole Chemical Library Identifies URB1483 as a New Antileishmanial Agent Devoid of Toxicity on Human Cells
  52. Gastrointestinal Tumors: Phytochemical and Drug Combinations Targeting the Hallmarks of Cancer
  53. Functional Classification of the ATM Variant c.7157C>A and In Vitro Effects of Dexamethasone
  54. A new humanized antibody is effective against pathogenic fungi in vitro
  55. Meet the Editorial Board Member
  56. Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma
  57. Intellectual Disability and Brain Creatine Deficit: Phenotyping of the Genetic Mouse Model for GAMT Deficiency
  58. Cohort Analysis of 67 Charcot-Marie-Tooth Italian Patients: Identification of New Mutations and Broadening of Phenotype Expression Produced by Rare Variants
  59. In Vitro Reduced Susceptibility to Pentavalent Antimonials of a Leishmania infantum Isolate from a Human Cutaneous Leishmaniasis Case in Central Italy
  60. Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib
  61. The nucleoplasmic interactions among Lamin A/C-pRB-LAP2α-E2F1 are modulated by dexamethasone
  62. Intracellular Redox-Modulated Pathways as Targets for Effective Approaches in the Treatment of Viral Infection
  63. Human Red Blood Cells Modulate Cytokine Expression in Monocytes/Macrophages Under Anoxic Conditions
  64. Activation of NRF2 and ATF4 Signaling by the Pro-Glutathione Molecule I-152, a Co-Drug of N-Acetyl-Cysteine and Cysteamine
  65. Carriage of Carbapenem-Resistant Enterobacterales in Adult Patients Admitted to a University Hospital in Italy
  66. Transcriptomic profile of ataxia telangiectasia cells treated for 30 days with a low dose of dexamethasone
  67. Preclinical developments of enzyme-loaded red blood cells
  68. Evaluation of a kDNA-Based qPCR Assay for the Detection and Quantification of Old World Leishmania Species
  69. I-152, a supplier of N-acetyl-cysteine and cysteamine, inhibits immunoglobulin secretion and plasma cell maturation in LP-BM5 murine leukemia retrovirus-infected mice by affecting the unfolded protein response
  70. Missense mutations in EDA and EDAR genes cause dominant syndromic tooth agenesis
  71. Redox homeostasis as a target for new antimycobacterial agents
  72. Efficient Cocaine Degradation by Cocaine Esterase-Loaded Red Blood Cells
  73. Basic and applied science at the time of COVID‐19
  74. Antiviral Properties of Flavonoids and Delivery Strategies
  75. The Ubiquitin Gene Expression Pattern and Sensitivity to UBB and UBC Knockdown Differentiate Primary 23132/87 and Metastatic MKN45 Gastric Cancer Cells
  76. Meet Our Editorial Board Member
  77. TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy
  78. Redox-Modulating Agents in the Treatment of Viral Infections
  79. Differentiation of Leishmania (L.) infantum, Leishmania (L.) amazonensis and Leishmania (L.) mexicana Using Sequential qPCR Assays and High-Resolution Melt Analysis
  80. Plasmid Replicon Typing of Antibiotic-Resistant Escherichia coli From Clams and Marine Sediments
  81. A comparative analysis of unintegrated HIV-1 DNA measurement as a potential biomarker of the cellular reservoir in the blood of patients controlling and non-controlling viral replication
  82. In Ataxia-Telangiectasia, Oral Betamethasone Administration Ameliorates Lymphocytes Functionality through Modulation of the IL-7/IL-7Rα Axis Paralleling the Neurological Behavior: A Comparative Report of Two Cases
  83. Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab
  84. Development of long circulating magnetic particle imaging tracers: use of novel magnetic nanoparticles and entrapment into human erythrocytes
  85. Ongoing Developments and Clinical Progress in Drug-Loaded Red Blood Cell Technologies
  86. Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy
  87. A Novel Homozygous Variant in the Fork-Head-Associated Domain of Polynucleotide Kinase Phosphatase in a Patient Affected by Late-Onset Ataxia With Oculomotor Apraxia Type 4
  88. Real-time PCR to differentiate among Leishmania (Viannia) subgenus, Leishmania (Leishmania) infantum and Leishmania (Leishmania) amazonensis: Application on Brazilian clinical samples
  89. DDIT4 gene expression is switched on by a new HDAC4 function in ataxia telangiectasia
  90. A negative feedback mechanism links UBC gene expression to ubiquitin levels by affecting RNA splicing rather than transcription
  91. Data on the differentiation among Leishmania (Viannia) spp., Leishmania (Leishmania) infantum and Leishmania (Leishmania) amazonensis in Brazilian clinical samples using real-time PCR
  92. Reduction of Immune Activation and Partial Recovery of Staphylococcal Enterotoxin B-Induced Cytokine Production After Switching to an Integrase Strand Transfer Inhibitor-Containing Regimen: Results from an Observational Cohort Study
  93. Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
  94. Red Blood Cell Membrane Processing for Biomedical Applications
  95. Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy
  96. Corrigendum: GSH-C4 Acts as Anti-inflammatory Drug in Different Models of Canonical and Cell Autonomous Inflammation Through NFκB Inhibition
  97. XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT
  98. Boosting GSH Using the Co-Drug Approach: I-152, a Conjugate of N-acetyl-cysteine and β-mercaptoethylamine
  99. Secosterol-B affects endoplasmic reticulum structure in endothelial cells
  100. Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38
  101. FKBP5 rs4713916: A Potential Genetic Predictor of Interindividual Different Response to Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease in a Real-Life Setting
  102. Effects in Cancer Cells of the Recombinant l-Methionine Gamma-Lyase from Brevibacterium aurantiacum. Encapsulation in Human Erythrocytes for Sustained l-Methionine Elimination
  103. Identification, Expression and Preliminary Characterization of a Recombinant Bifunctional Enzyme of Photobacterium damselae subsp. piscicida with Glutamate Decarboxylase/Transaminase Activity
  104. Glutathione increase by the n-butanoyl glutathione derivative (GSH-C4) inhibits viral replication and induces a predominant Th1 immune profile in old mice infected with influenza virus
  105. Magnetic Manipulation of Blood Conductivity with Superparamagnetic Iron Oxide-Loaded Erythrocytes
  106. Biochemical Properties and Oxalate‐Degrading Activity of Oxalate Decarboxylase from Bacillus subtilis at Neutral pH
  107. Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study
  108. GSH-C4 Acts as Anti-inflammatory Drug in Different Models of Canonical and Cell Autonomous Inflammation Through NFκB Inhibition
  109. The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses?
  110. Evaluation of PCR-based methods for the identification of enteroaggregative hemorrhagic Escherichia coli in sprouts
  111. Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors
  112. Exploiting genetic polymorphisms in metabolic enzymes for rapid screening of Leishmania infantum genotypes
  113. Humanization of Antibodies using a Statistical Inference Approach
  114. Induction of ubiquitin C (UBC ) gene transcription is mediated by HSF1: role of proteotoxic and oxidative stress
  115. Preclinical evaluation of an innovative anti-TAM approach based on zoledronate-loaded erythrocytes
  116. Leishmania Infection Induces MicroRNA hsa-miR-346 in Human Cell Line-Derived Macrophages
  117. Real-time PCR applications for diagnosis of leishmaniasis
  118. A new therapy prevents intellectual disability in mouse with phenylketonuria
  119. Comparison of the Diatheva STEC FLUO with BAX System Kits for Detection of O157:H7 and Non-O157 Shiga Toxin-Producing Escherichia coli (STEC) in Ground Beef and Bean Sprout Samples Using Different Enrichment Protocols
  120. Proteomics and transcriptomics analyses of ataxia telangiectasia cells treated with Dexamethasone
  121. Ferucarbotran-loaded red blood cells as long circulating MRI contrast agents: first in vivo results in mice
  122. Ataxia-telangiectasia
  123. Detection of Shiga toxin-producing Escherichia coli (STEC) in ground beef and bean sprouts: Evaluation of culture enrichment conditions
  124. MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine
  125. Endothelial cells, endoplasmic reticulum stress and oxysterols
  126. Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells
  127. Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients
  128. Engineered red blood cells as therapeutic agents
  129. Endoplasmic reticulum stress and unfolded protein response in infection by intracellular parasites
  130. In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia
  131. ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T
  132. Validation and application of a quantitative real-time PCR assay to detect common wheat adulteration of durum wheat for pasta production
  133. The use of kDNA minicircle subclass relative abundance to differentiate between Leishmania (L.) infantum and Leishmania (L.) amazonensis
  134. Comparative analysis of the standard PCR-Based Replicon Typing (PBRT) with the commercial PBRT-KIT
  135. Determination of Interference DuringIn VitroPyrogen Detection: Development and Characterization of a Cell-Based Assay
  136. Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor
  137. Reengineering red blood cells for cellular therapeutics and diagnostics
  138. Intravascular contrast agents in diagnostic applications: Use of red blood cells to improve the lifespan and efficacy of blood pool contrast agents
  139. Glutathione and its derivatives for the treatment of microbial infections.
  140. Ex vivo encapsulation of dexamethasone sodium phosphate into human autologous erythrocytes using fully automated biomedical equipment
  141. Leishmania infantum Induces Mild Unfolded Protein Response in Infected Macrophages
  142. Nano-Mechanical Characterization of Ataxia Telangiectasia Cells Treated with Dexamethasone
  143. Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution
  144. Characterization of ferucarbotran-loaded RBCs as long circulating magnetic contrast agents
  145. Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response
  146. Enterococcus faeciumST17 from Coastal Marine Sediment Carrying Transferable Multidrug Resistance Plasmids
  147. Gender effects of single nucleotide polymorphisms and miRNAs targeting clock-genes in metastatic colorectal cancer patients (mCRC)
  148. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4+ T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial
  149. LP-BM5 infection and glutathione
  150. Erythrocyte-mediated delivery of recombinant enzymes
  151. Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer
  152. Validation of a Reversed-Phase High Performance Liquid Chromatography Method for the Simultaneous Analysis of Cysteine and Reduced Glutathione in Mouse Organs
  153. Modulation of Stat-1 in Human Macrophages Infected with Different Species of Intracellular Pathogenic Bacteria
  154. Selection of Vaccine Candidates for Fish Pasteurellosis Using Reverse Vaccinology and an In Vitro Screening Approach
  155. Process development of a human recombinant diabody expressed in E. coli: engagement of CD99-induced apoptosis for target therapy in Ewing’s sarcoma
  156. Retrieving embryo genetic information from spent culture medium
  157. Dynamic transcription of ubiquitin genes under basal and stressful conditions and new insights into the multiple UBC transcript variants
  158. The Human Antibody Fragment DIATHIS1 Specific for CEACAM1 Enhances Natural Killer Cell Cytotoxicity Against Melanoma Cell Lines In Vitro
  159. Adherence and intracellular survival within human macrophages of Enterococcus faecalis isolates from coastal marine sediment
  160. Molecular Dissection of the Human Ubiquitin C Promoter Reveals Heat Shock Element Architectures with Activating and Repressive Functions
  161. Inhibition of Testosterone Aromatization by the Indole-3-carbinol Derivative CTet in CYP19A1-overexpressing MCF-7 Breast Cancer Cells
  162. Label-free quantification of Tacrolimus in biological samples by atomic force microscopy
  163. HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial
  164. Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia
  165. Validation according to ISO/TS 12869:2012 of a molecular method for the isolation and quantification of Legionella spp. in water
  166. Selective protein detection with a dsLNA-functionalized nanopore
  167. Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies
  168. Anti influenza therapy
  169. Effect of starvation on survival and virulence expression of Aeromonas hydrophila from different sources
  170. CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin
  171. Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients
  172. A Real Time PCR Platform for the Simultaneous Quantification of Total and Extrachromosomal HIV DNA Forms in Blood of HIV-1 Infected Patients
  173. Erythrocyte-mediated delivery of phenylalanine ammonia lyase for the treatment of phenylketonuria in BTBR-Pahenu2 mice
  174. Application of qPCR in conjunctival swab samples for the evaluation of canine leishmaniasis in borderline cases or disease relapse and correlation with clinical parameters
  175. Red Blood Cells as Carriers of Iron Oxide-Based Contrast Agents for Diagnostic Applications
  176. Enhancing neutral lipid content in Skeletonema marinoi through multiple phase growth in a bench photobioreactor
  177. Consensus HIV-1 subtype A integrase and its raltegravir-resistant variants: Design and characterization of the enzymatic properties
  178. Promoter-specific relevance of histone modifications induced by dexamethasone during the regulation of pro-inflammatory mediators
  179. Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells
  180. Blocking monocyte transmigration in in vitro system by a human antibody scFv anti-CD99. Efficient large scale purification from periplasmic inclusion bodies in E. coli expression system
  181. Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy
  182. Effect of the N-butanoyl glutathione (GSH) derivative and acyclovir on HSV-1 replication and Th1 cytokine expression in human macrophages
  183. Clinical impact of the HGF/MET pathway activation in patients with advanced gastric cancer treated with palliative chemotherapy
  184. Forward subtractive libraries containing genes transactivated by dexamethasone in ataxia-telangiectasia lymphoblastoid cells
  185. USPIO-loaded red blood cells as a biomimetic MR contrast agent: a relaxometric study
  186. An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas
  187. Approaches to erythrocyte-mediated drug delivery
  188. Detection and Characterization of Leishmania (Leishmania) and Leishmania (Viannia) by SYBR Green-Based Real-Time PCR and High Resolution Melt Analysis Targeting Kinetoplast Minicircle DNA
  189. Erythrocytes as Carriers for Drugs and Contrast Agents
  190. Intra-Erythrocyte Infusion of Dexamethasone Reduces Neurological Symptoms in Ataxia Teleangiectasia Patients: Results of a Phase 2 Trial
  191. Photobacteriosis: Prevention and Diagnosis
  192. Isolation of a new human scFv antibody recognizing a cell surface binding site to CEACAM1. Large yield production, purification and characterization in E. coli expression system
  193. New Strategies to Prolong the In Vivo Life Span of Iron-Based Contrast Agents for MRI
  194. Anti-inflammatory effect of ubiquinol-10 on young and senescent endothelial cells via miR-146a modulation
  195. Recent advances in synthesis, characterization of hydroxyapatite/polyurethane composites and study of their biocompatible properties
  196. Yin Yang 1 Intronic Binding Sequences and Splicing Elicit Intron-Mediated Enhancement of Ubiquitin C Gene Expression
  197. Genomic DNA in human blastocoele fluid
  198. Neutral Lipid Content and Biomass Production in Skeletonema marinoi (Bacillariophyceae) Culture in Response to Nitrate Limitation
  199. Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection
  200. Erythrocytes-mediated Delivery of Dexamethasone 21-phosphate in Steroid-dependent Ulcerative Colitis
  201. Magnetic red blood cells as new contrast agents for MRI applications
  202. Molecules Altering the Intracellular Thiol Content Modulate NF-kB and STAT-1/IRF-1 Signalling Pathways and IL-12 p40 and IL-27 p28 Production in Murine Macrophages
  203. Antitumoral Activity of Indole-3-carbinol Cyclic tri- and Tetrameric Derivatives Mixture in Human Breast Cancer Cells: In Vitro and In Vivo Studies
  204. Use of red blood cells as new strategy to avoid the rapid clearance of SPIOs nanoparticles
  205. Isolation of a novel gene from Photobacterium damselae subsp. piscicida and analysis of the recombinant antigen as promising vaccine candidate
  206. Red blood cells as carriers in magnetic particle imaging
  207. Deciphering the single-cell omic: innovative application for translational medicine
  208. CEACAM1 is a Privileged Cell Surface Antigen to Design Novel ScFv Mediated-Immunotherapies of Melanoma, Lung Cancer and Other Types of Tumors
  209. HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies
  210. Dexamethasone Partially Rescues Ataxia Telangiectasia-mutated (ATM) Deficiency in Ataxia Telangiectasia by Promoting a Shortened Protein Variant Retaining Kinase Activity
  211. Induction of Endoplasmic Reticulum Stress Response by the Indole-3-Carbinol Cyclic Tetrameric Derivative CTet in Human Breast Cancer Cell Lines
  212. Palytoxin and an Ostreopsis Toxin Extract Increase the Levels of mRNAs Encoding Inflammation-Related Proteins in Human Macrophages via p38 MAPK and NF-κB
  213. The expression and modulation of CEACAM1 and tumor cell transformation
  214. High Let-7a MicroRNA Levels in KRAS-Mutated Colorectal Carcinomas May Rescue Anti-EGFR Therapy Effects in Patients with Chemotherapy-Refractory Metastatic Disease
  215. Microbiological Surveillance of a Bovine Raw Milk Farm Through Multiplex Real-Time PCR
  216. Unique Toxin Profile of a Mediterranean Ostreopsis cf. ovata Strain: HR LC-MSn Characterization of Ovatoxin-f, a New Palytoxin Congener
  217. Development of a multilevel approach for the evaluation of nanomaterials’ toxicity
  218. Erythrocytes as a novel delivery vehicle for biologics: from enzymes to nucleic acid-based therapeutics
  219. Erythrocytes as carriers for drugs: the transition from the laboratory to the clinic is approaching
  220. Involvement of Stat1 in the Phagocytosis ofM. avium
  221. Red Blood Cells as Magnetic Carriers for MPI Applications
  222. Corrigendum: Autoantibodies Against the Exocrine Pancreas in Autoimmune Pancreatitis: Gene and Protein Expression Profiling and Immunoassays Identify Pancreatic Enzymes as a Major Target of the Inflammatory Process
  223. Genetic Activation of the MET Pathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer
  224. Application of the standard addition method for the absolute quantification of neutral lipids in microalgae using Nile red
  225. Binding force measurement of NF-κB–ODNs interaction: An AFM based decoy and drug testing tool
  226. Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules
  227. Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs
  228. Redox Regulation of the Influenza Hemagglutinin Maturation Process: A New Cell-Mediated Strategy for Anti-Influenza Therapy
  229. Glucocorticoid resistance in Crohn's disease and ulcerative colitis: an association study investigating GR and FKBP5 gene polymorphisms
  230. Dexamethasone restrains ongoing expression of interleukin-23p19 in peripheral blood-derived human macrophages
  231. Drug delivery by red blood cells
  232. Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer
  233. A practical and expeditious method for the preparation of the potential anticancer agent 5,6,11,12,17,18,23,24-octahydrocyclododeca[1,2-b:4,5-b′:7,8-b″:10,11-b‴]tetraindole (CTet)
  234. Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: Clinical outcome according to KRAS and BRAF mutational status
  235. Development of an oligonucleotide microarray for the detection and monitoring of marine dinoflagellates
  236. Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents
  237. The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines
  238. Role of KRAS let-7 LCS6 SNP in metastatic colorectal cancer patients
  239. Increased Bone Marrow Interleukin-7 (IL-7)/IL-7R Levels but Reduced IL-7 Responsiveness in HIV-Positive Patients Lacking CD4+ Gain on Antiviral Therapy
  240. The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice
  241. Electrical characterization of DNA-functionalized solid state nanopores for bio-sensing
  242. Human erythrocytes as nanoparticle carriers for magnetic particle imaging
  243. Improved cellular uptake of functionalized single-walled carbon nanotubes
  244. Host genetic variants in the IGF binding protein-3 impact on survival of patients with advanced gastric cancer treated with palliative chemotherapy
  245. Autoantibodies Against the Exocrine Pancreas in Autoimmune Pancreatitis: Gene and Protein Expression Profiling and Immunoassays Identify Pancreatic Enzymes as a Major Target of the Inflammatory Process
  246. Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking
  247. A multiplex magnetic capture hybridisation and multiplex Real-Time PCR protocol for pathogen detection in seafood
  248. Label-free quantification of activated NF-κB in biological samples by atomic force microscopy
  249. Synthesis and Biological Evaluation of a γ-Cyclodextrin-based Formulation of the Anticancer Agent 5,6,11,12,17,18,23,24- Octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet)
  250. Oxidized Ultrashort Nanotubes as Carbon Scaffolds for the Construction of Cell-Penetrating NF-κB Decoy Molecules
  251. Genetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab–irinotecan
  252. Molecular Predictors of Efficacy to Anti-EGFR Agents in Colorectal Cancer Patients
  253. The preventive phase I trial with the HIV-1 Tat-based vaccine
  254. A potent enhancer element in the 5′-UTR intron is crucial for transcriptional regulation of the human ubiquitin C gene
  255. Parallel Conduction of the Phase I Preventive and Therapeutic Trials Based on the Tat Vaccine Candidate
  256. A new platform for Real-Time PCR detection of Salmonella spp., Listeria monocytogenes and Escherichia coli O157 in milk
  257. Expression and characterization of the periplasmic cobalamin-binding protein ofPhotobacterium damselaesubsp.piscicida
  258. NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population
  259. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity
  260. Development of a multiplex PCR assay forPhotobacterium damselaesubsp.piscicidaidentification in fish samples
  261. HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis
  262. KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
  263. PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer
  264. SIMULTANEOUS DIRECT DETECTION OFSALMONELLASPP.,LISTERIA MONOCYTOGENESANDESCHERICHIA COLIO157 IN MILK SAMPLES BY MAGNETIC EXTRACTION AND MULTIPLEX PCR
  265. Expression, Purification, and Characterization of the Recombinant Putative Periplasmic Hemin-Binding Protein (HutB) ofPhotobacterium damselaesubsp.piscicida
  266. De-ubiquitylation is the most critical step in the ubiquitin-mediated homeostatic control of the NF-κB/IKK basal activity
  267. Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up
  268. Erythrocytes as carriers of antisense PNA addressed against HIV-1gag-poltransframe domain
  269. Different prelamin A forms accumulate in human fibroblasts: a study in experimental models and progeria
  270. Analysis of rRNA gene content in the Mediterranean dinoflagellate Alexandrium catenella and Alexandrium taylori: implications for the quantitative real-time PCR-based monitoring methods
  271. HIV-1 Tat Addresses Dendritic Cells to Induce a Predominant Th1-Type Adaptive Immune Response That Appears Prevalent in the Asymptomatic Stage of Infection
  272. Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS)
  273. GSH and analogs in antiviral therapy
  274. High resolution melting (HRM) analysis for the detection of ER22/23EK, BclI, and N363S polymorphisms of the glucocorticoid receptor gene
  275. Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer
  276. High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice
  277. Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-Loaded Erythrocyte Ghost Cells
  278. The therapeutic phase I trial of the recombinant native HIV-1 Tat protein
  279. VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population
  280. Erythrocyte-Mediated Delivery of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study
  281. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes
  282. Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer
  283. Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
  284. Ubiquitin over-expression promotes E6AP autodegradation and reactivation of the p53/MDM2 pathway in HeLa cells
  285. Selective Killing ofMycobacterium avium–Infected Macrophages by Inhibition of Phosphorylated Signal Transducer and Activator of Transcription Type 1
  286. A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: A case control study in an Italian population
  287. New Biomimetic Constructs for Improved In Vivo Circulation of Superparamagnetic Nanoparticles
  288. Pharmacogenetic Profiling for Cetuximab Plus Irinotecan Therapy in Patients With Refractory Advanced Colorectal Cancer
  289. Endogastric capsule for E-cadherin gene (CDH1) promoter hypermethylation assessment in DNA from gastric juice of diffuse gastric cancer patients
  290. Prolonged Islet Allograft Survival in Diabetic Mice Upon Macrophage Depletion by Clodronate-Loaded Erythrocytes
  291. A three-year longitudinal study on the effects of a diet containing genetically modified Bt176 maize on the health status and performance of sheep
  292. Inhibition of murine AIDS by pro-glutathione (GSH) molecules
  293. Cell-based drug delivery
  294. Detection and quantification of Prymnesium parvum (Haptophyceae) by real-time PCR
  295. Inhibition of HIV-1 Replication in Macrophages by Red Blood Cell-Mediated Delivery of a Heterodinucleotide of Lamivudine and Tenofovir
  296. Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay
  297. Candidate HIV-1 gp140ΔV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge
  298. Detection of Listeria monocytogenes using a commercial PCR kit and different DNA extraction methods
  299. Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment
  300. Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy
  301. Genotyping OLR1 Gene: A Genomic Biomarker for Cardiovascular Diseases
  302. Immunization with HIV protease peptides linked to syngeneic erythrocytes
  303. Long-term Treatment With Autologous Red Blood Cells Loaded With Dexamethasone 21–Phosphate in Pediatric Patients Affected by Steroid-dependent Crohn Disease
  304. Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 Chemotherapy
  305. Current molecular techniques for the detection of microbial pathogens
  306. Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir
  307. High throughput HPLC-ESI-MS method for the quantitation of dexamethasone in blood plasma
  308. Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer
  309. Candidate HIV-1 Tat vaccine development: from basic science to clinical trials
  310. Administration of Fludarabine-Loaded Autologous Red Blood Cells in Simian Immunodeficiency Virus-Infected Sooty Mangabeys Depletes pSTAT-1-Expressing Macrophages and Delays the Rebound of Viremia after Suspension of Antiretroviral Therapy
  311. Erythrocytes as a controlled drug delivery system: Clinical evidences
  312. Fludarabine delivery by autologous red blood cells induces macrophage depletion in chronically SIV-infected Sooty Mangabeys
  313. Monitoring of HAB species in the Mediterranean Sea through molecular methods
  314. A combination of diagnostic tools for rapid screening of ovine listeriosis
  315. Monitoring ofAlexandriumspecies in the Mediterranean Sea using a combined filter system–PCR assay detection method
  316. Immune response and protection by DNA vaccines expressing antigen 85B ofMycobacterium tuberculosis
  317. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART
  318. The Use of Magnetic Nanoparticles in the Development of New Molecular Detection Systems
  319. Capture probe conjugated to paramagnetic nanoparticles for purification of Alexandrium species (Dinophyceae) DNA from environmental samples
  320. Antiviral and Immunomodulatory Properties of New Pro-Glutathione (GSH) Molecules
  321. Pharmacogenetic Profiling and Clinical Outcome of Patients With Advanced Gastric Cancer Treated With Palliative Chemotherapy
  322. In Vitro Inhibition of Promyelocytic Leukemia/Retinoic Acid Receptor-α (PML/RARα) Expression and Leukemogenic Activity by DNA/LNA Chimeric Antisense Oligos
  323. Periodic Treatment with Autologous Erythrocytes Loaded with Dexamethasone 21-Phosphate for Fistulizing Pediatric Crohn's Disease
  324. Development of a magnetic capture hybridization-PCR assay for Listeria monocytogenes direct detection in milk samples
  325. Perturbations of Cell Cycle Control in T Cells Contribute to the Different Outcomes of Simian Immunodeficiency Virus Infection in Rhesus Macaques and Sooty Mangabeys
  326. Development of a qualitative PCR method for the Alexandrium spp. (Dinophyceae) detection in contaminated mussels (Mytilus galloprovincialis)
  327. Vaccines based on the native HIV Tat protein and on the combination of Tat and the structural HIV protein variant ΔV2 Env
  328. Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population
  329. Erythrocytes-Mediated Delivery of Dexamethasone in Steroid-Dependent IBD Patients-A Pilot Uncontrolled Study
  330. Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype
  331. Mechanisms of Action and Antiproliferative Properties of Brassica oleracea Juice in Human Breast Cancer Cell Lines
  332. Prognostic Role of Thymidylate Synthase Polymorphisms in Gastric Cancer Patients Treated with Surgery and Adjuvant Chemotherapy
  333. Development of new procedures for the isolation of phytoplankton DNA from fixed samples
  334. Prognostic Role of Interleukin-1β Gene and Interleukin-1 Receptor Antagonist Gene Polymorphisms in Patients With Advanced Gastric Cancer
  335. Erythrocyte-based drug delivery
  336. Loss of CD127 Expression Defines an Expansion of Effector CD8+T Cells in HIV-Infected Individuals
  337. Macrophage depletion induced by clodronate-loaded erythrocytes
  338. Targeting Nucleotide Dimers Containing Antiviral Nucleosides
  339. Bovine hexokinase type I: Full-length cDNA sequence and characterisation of the recombinant enzyme
  340. Editorial
  341. Locked Nucleic Acids (LNA): Versatile Tools for Designing Oligonucleotide Decoys with High Stability and Affinity
  342. Direct detection of Listeria monocytogenes from milk by magnetic based DNA isolation and PCR
  343. Development of a Real-Time PCR Assay Using SYBR Green I for Provirus Load Quantification in a Murine Model of AIDS
  344. Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application
  345. Low doses of dexamethasone constantly delivered by autologous erythrocytes slow the progression of lung disease in cystic fibrosis patients
  346. Prognostic Analysis of E-Cadherin Gene Promoter Hypermethylation in Patients with Surgically Resected, Node-Positive, Diffuse Gastric Cancer
  347. Purification and characterization of a recombinant listeriolysin O expressed in Escherichia coli and possible diagnostic applications
  348. Transcription factor decoy oligonucleotides modified with locked nucleic acids: an in vitro study to reconcile biostability with binding affinity
  349. Effect of listeriolysin O-loaded erythrocytes on Mycobacterium avium replication within macrophages
  350. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs
  351. Development of a Real-Time PCR Assay for Rapid Detection and Quantification of Alexandrium minutum (a Dinoflagellate)
  352. Downregulation of nitric oxide formation by cytosolic phospholipase A2-released arachidonic acid
  353. Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients
  354. Predictive and Prognostic Role of E-Cadherin Protein Expression in Patients with Advanced Gastric Carcinomas Treated with Palliative Chemotherapy
  355. Association of thymidylate synthase polymorphisms with gastric cancer susceptibility
  356. Biochemical characterization of two GALK1 mutations in patients with galactokinase deficiency
  357. Drug Delivery through Phagocytosis of Red Blood Cells
  358. Specific Changes in the Posttranslational Regulation of Nucleolin in Lymphocytes from Patients Infected with Human Immunodeficiency Virus
  359. Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression
  360. Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections
  361. A new one-step RT-PCR method for virus quantitation in murine AIDS
  362. DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge
  363. Screening E-Cadherin Germline Mutations in Italian Patients with Familial Diffuse Gastric Cancer: An Analysis in the District of Urbino, Region Marche, Central Italy
  364. High-level expression of the Listeria monocytogenes listeriolysin O in Escherichia coli and preliminary characterization of the purified protein
  365. Marine diatom growth on different forms of particulate silica: evidence of cell/particle interaction
  366. The G/A Nucleotide Change at cDNA Position 2494 in the E-Cadherin Gene (CDH1): Analysis in Italian Patients
  367. Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model
  368. Seasonal Blooms of the HAB Dinoflagellate Alexandrium taylori Balech in a New Mediterranean Area (Vulcano, Aeolian Islands)
  369. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer
  370. Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine
  371. Repeated Cycles of Alternate Administration of Fludarabine and Zidovudine Plus Didanosine Inhibits Murine AIDS and Reduces Proviral DNA Content in Lymph Nodes to Undetectable Levels
  372. HIV-1 Tat-Based Vaccines: From Basic Science to Clinical Trials
  373. Inhibition of Macrophage iNOS by Selective Targeting of Antisense PNA†
  374. Design and characterization of decoy oligonucleotides containing locked nucleic acids
  375. Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides
  376. Exogenous Interleukin-2 Administration Corrects the Cell Cycle Perturbation of Lymphocytes from Human Immunodeficiency Virus-Infected Individuals
  377. Modulation of ICAM-1 Expression in ECV304 Cells by Macrophage-Released Cytokines
  378. The potency of acyclovir can be markedly different in different cell types
  379. Inhibition of Proteasome Activity Strongly Affects Kiwifruit Pollen Germination. Involvement of the Ubiquitin/Proteasome Pathway as a Major Regulator
  380. Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus
  381. Inhibition of HIV-1 Replication in Macrophages by Red Blood Cell-Mediated Delivery of a Heterodinucleotide of Azidothymidine and 9-(R)-2-(Phosphono Methoxypropyl)adenine
  382. Identification of Blood Erythroid Markers Useful in Revealing Erythropoietin Abuse in Athletes
  383. Abnormal intracellular kinetics of cell-cycle-dependent proteins in lymphocytes from patients infected with human immunodeficiency virus: a novel biologic link between immune activation, accelerated T-cell turnover, and high levels of apoptosis
  384. Antioxidant capacity of extra-virgin olive oils
  385. New drug combinations for the treatment of murine AIDS and macrophage protection
  386. Identification of the main ubiquitination site in human erythroid α-spectrin
  387. The Ubiquitin-Dependent Proteolytic System and other Potential Targets for the Modulation of Nuclear Factor-kB (NF-kB)
  388. A new acyclic heterodinucleotide active against Human Immunodeficiency Virus and Herpes Simplex Virus
  389. Structure of the 5′ region of the human hexokinase type I (HKI) gene and identification of an additional testis-specific HKI mRNA
  390. Ubiquitin/proteasome system
  391. Selective Inhibition of NF-kB Activation and TNF-α Production in Macrophages by Red Blood Cell-Mediated Delivery of Dexamethasone
  392. Identification of ubiquitinated repeats in human erythroid α-spectrin
  393. Inhibition of Murine AIDS by Alternate Administration of Azidothymidine and Fludarabine Monophosphate
  394. New Treatment Protocol Including Lympholytic and Antiretroviral Drugs to Inhibit Murine AIDS
  395. Metabolism, mitochondrial uptake and toxicity of 2′,3′-dideoxycytidine
  396. Binding of non-catalytic ATP to human hexokinase I highlights the structural components for enzyme–membrane association control
  397. Influence of nutrient ratios on the in vitro extracellular polysaccharide production by marine diatoms from the Adriatic Sea
  398. Unscheduled cyclin B expression and p34 cdc2 activation in T lymphocytes from HIV-infected patients
  399. MONITORING ERYTHROPOIETIN ABUSE IN ATHLETES
  400. Activation of the ubiquitin proteolytic system in murine acquired immunodeficiency syndrome affects IkappaBalpha turnover
  401. IDENTIFICATION OF ALEXANDRIUM (DINOPHYCEAE) SPECIES USING PCR AND rDNA-TARGETED PROBES
  402. Alteration of α-spectrin ubiquitination due to age-dependent changes in the erythrocyte membrane
  403. Protein Degradation and Apoptotic Death in Lymphocytes during Fiv Infection: Activation of the Ubiquitin–Proteasome Proteolytic System
  404. Liposomes as carriers of the antiretroviral agent dideoxycytidine-5′-triphosphate
  405. Synthesis and Biological Application of a New Heterodinucleotide with Both Anti-HSV and Anti-HIV Activity
  406. cDNA Sequence of the Human Erythroid -Spectrin: Identification of a Base Deletion in the Sequence Database
  407. Efficient inhibition of macrophage TNF-α production upon targeted delivery of K48R ubiquitin
  408. Heterodimer-Loaded Erythrocytes as Bioreactors for Slow Delivery of the Antiviral Drug Azidothymidine and the Antimycobacterial Drug Ethambutol
  409. Expression, Purification, and Characterization of a Recombinant Erythroid-Specific Hexokinase Isozyme
  410. Competitive PCR for Quantification of BM5d Proviral DNA in Mice with AIDS
  411. Drug delivery and targeting system
  412. Structure of the human hexokinase type I gene and nucleotide sequence of the 5′ flanking region
  413. Macrophage Protection Against Human Immunodeficiency Virus or Herpes Simplex Virus by Red Blood Cell-Mediated Delivery of a Heterodinucleotide of Azidothymidine and Acyclovir
  414. AIDS Vaccination Studies Using an Ex Vivo Feline Immunodeficiency Virus Model: Homologous Erythrocytes as a Delivery System for Preferential Immunization with Putative Protective Antigens
  415. Inhibition of Murine AIDS by a New Azidothymidine Homodinucleotide
  416. Structure and expression of the human ubiquitin fusion–degradation gene (UFD1L)
  417. An Erythroid-Specific Exon Is Present in the Human Hexokinase Gene
  418. An Erythroid-Specific Exon Is Present in the Human Hexokinase Gene
  419. Expression of hexokinase mRNA in human hippocampus
  420. Use of Nonvolatile Buffers in Liquid Chromatography/Mass Spectrometry:  Advantages of Capillary-Scale Particle Beam Interfacing
  421. Antiretroviral Effect of Combined Zidovudine and Reduced Glutathione Therapy in Murine AIDS
  422. Oxidative Protein Damage and Degradation in Lymphocytes from Patients Infected with Human Immunodeficiency Virus
  423. Ubiquitin conjugation to endogenous proteins in the dormant tuber of Helianthus tuberosus and during the first cell cycle
  424. 2′,3′-Dideoxycytidine cytotoxicity in human macrophages
  425. Targeting antiviral nucleotide analogues to macrophages
  426. Up-Regulation of the Ubiquitin-Conjugating and Proteolytic Systems in Murine Acquired Immunodeficiency Syndrome
  427. Molecular bases of hexokinase deficiency
  428. The Inhibitory Effect of ddC on Human Immunodeficiency Virus Replication Diminishes in Cells that are Chronically Exposed to the Drug
  429. Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in mice
  430. Structural determinants that make hexokinase susceptible to ubiquitin-and ATP- dependent proteolysis
  431. Structure of the human hexokinase type I gene
  432. Identification of α-Spectrin Domains Susceptible to Ubiquitination
  433. Increased microbicidal activity of human monoblastoid cells upon long-term exposure to dideoxycytidine
  434. Encapsulation, metabolism and release of 2-fluoro-ara-AMP from human erythrocytes
  435. Inhibition of Murine AIDS by Reduced Glutathione
  436. Inhibition of Murine AIDS by Combination of AZT and Dideoxycytidine 5'-Triphosphate
  437. MODULATION OF THE HEAT SHOCK UBIQUITIN POOL IN SKELETONEMA COSTATUM (BACILLARIOPHYCEAE)1
  438. Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection.
  439. Azidothymidine Homodinucleotide-Loaded Erythrocytes as Bioreactors for Slow Delivery of the Antiretroviral Drug Azidothymidine
  440. High-Level Expression and Purification of a Human “Mini”-hexokinase
  441. Assignment of the hexokinase type 3 gene (HK3) to human chromosome band 5q35.3 by somatic cell hybrids and in situ hybridization
  442. Three new mutations (P183T, V150L, 528insG) and eleven sequence polymorphisms in Italian patients with galactose-1-phosphate uridyltransferase (GALT) deficiency
  443. Lactate catabolism by enzyme‐loaded red blood cells
  444. 2′,3′-Dideoxycytidine metabolism in a new drug-resistant cell line
  445. Inhibition of HIV-1 and LP-BM5 Replication in Macrophages by Dideoxycytidine and Dideoxycytidine 5′-Triphosphate
  446. Effect of Antiviral Treatments on the Bone Marrow in Murine AIDS
  447. 2′,3′-Dideoxycytidine induced drug resistance in human cells
  448. Efficacy and Toxicity of Long-Term Administration of 2′,3′-dideoxycytidine in the LP-BM5 Murine-Induced Immunodeficiency Model
  449. UBIQUITIN INSKELETONEMA COSTATUM
  450. FIV infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine 5′-triphosphate
  451. Ubiquitin Is Conjugated to the Cytoskeletal Protein α-Spectrin in Mature Erythrocytes
  452. Hexokinase Mutations that Produce Nonspherocytic Hemolytic Anemia
  453. Effect of heat stress on polyamine content and protein pattern in Skeletonema costatum
  454. Modulated red blood cell survival by membrane protein clustering
  455. Red blood cells as a delivery system for AZT
  456. Targeting dexamethasone to macrophages
  457. Preparation and characterization of biotinylated red blood cells
  458. Feline Immunodeficiency Virus Infection of Macrophages:In Vitroandin VivoInhibition by Dideoxycytidine-5′-triphosphate-Loaded Erythrocytes
  459. Red blood cell phagocytosis following hexokinase inactivation
  460. Localization and age-dependent expression of hexokinase mRNA in the rat brain
  461. The soluble but not mitochondrially bound hexokinase is a substrate for the ATP- and ubiquitin-dependent proteolytic system
  462. HPLC Analysis of Taurine in Human Plasma Sample Using the Dabs-Ci Reagent with Sensitivity at Picomole Level
  463. The female longevity phenomenon. Hypotheses on some molecular and cell biology aspects
  464. Methanol detoxification by enzyme‐loaded erythrocytes
  465. Molecular analysis of G6PD variants in northern Italy: a study on the population from the Ferrara district
  466. Phagocytosis reduces HIV-1 production in human monocytes/macrophages infected in vitro
  467. Red Blood Cell Aging. Proceedings of a Symposium Held in Urbino, Italy, 24-26 September 1990.Mauro Magnani , Antonio De Flora
  468. The bone marrow in murine AIDS
  469. Direct observation of hexokinase translocation in stimulated macrophages
  470. Red blood cell age dependent modifications of inositol 1,4,5-trisphosphate
  471. Glucose-6-Phosphate Dehydrogenase Nucleotide 1311 Polymorphism in Central Italy (Marche Region)
  472. Intracellular distribution of hexokinase in rabbit brain
  473. In vitro and in vivo toxicity of 2′,3′-dideoxycytidine in mice
  474. Intracellular Distribution of Protein as a Determinant for Ubiquitination and Proteolytic Degradation
  475. Red blood cells as an antigen‐delivery system
  476. Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studies.
  477. A recombinant human ‘mini’-hexokinase is catalytically active and regulated by hexose 6-phosphates
  478. In vitro targeting of erythrocytes to cytotoxic T‐cells by coupling of Thy‐1.2 monoclonal antibody
  479. Increased glucose metabolism by enzyme‐loaded erythrocytes in vitro and in vivo normalization of hyperglycemia in diabetic mice
  480. Acetaldehyde Oxidation by Aldehyde Dehydrogenase Loaded Erythrocytes
  481. Analysis of amino acids as DABS-derivatives with a sensitivity to the femtomole level using RP-HPLC narrow-bore columns
  482. Comparison of Uricase-Bound and Uricase-Loaded Erythrocytes as Bioreactors for Uric Acid Degradation
  483. Normalization of Hyperglycemia in Diabetic Mice by Enzyme-Loaded Erythrocytes
  484. Red Blood Cells as Advanced Drug Delivery Systems for Antiviral Nucleoside Analogues
  485. Xenobiotic Detoxification by GSH-Loaded Erythrocytes
  486. The Use of Resealed Erythrocytes as Carriers and Bioreactors
  487. Cloning and expression of a new human polypeptide which regulates protein phosphorylation in Escherichia coli
  488. Human red blood cells as bioreactors for the inactivation of harmful xenobiotics
  489. Cell age dependent decay of human erythrocytes glutathione S-transferase
  490. Red Blood Cell Aging
  491. Free Radicals Promote “In Vitro” a Different Intracellular Decay of Rabbit Reticulocyte and Erythrocyte Glycolytic Enzymes
  492. Glucose-6-Phosphate Dehydrogenase Lodi^844C: A Study on Its Expression in Blood Cells and Muscle
  493. In vitro toxicity and metabolism of 2′,3′-dideoxycytidine, an inhibitor of human immunodeficiency virus infectivity
  494. Role and Mechanism of Hexokinase Decay During Reticulocyte Maturation and Cell Aging
  495. Immunological quantification of human hexokinase type I
  496. A nonlinear three-compartiment model for the administration of 2′,3′-dideoxycytidine by using red blood cells as bioreactors
  497. Preparation and characterization of monoclonal antibodies to human hexokinase type I
  498. Hexokinase: one gene or two [letter; comment]
  499. ATP modifications in hexokinase deficient fibroblasts exposed to nutrient shifts
  500. Similarities and differences between human and rat hexokinases type I
  501. IN VIVO ACCELERATED ACETALDEHYDE METABOLISM USING ACETALDEHYDE DEHYDROGENASE-LOADED ERYTHROCYTES
  502. Acetaldehyde Dehydrogenase-Loaded Erythrocytes as Bioreactors for the Removal of Blood Acetaldehyde
  503. Cell age dependent decay of human erythrocytes glucose-6-phosphate isomerase
  504. Human red blood cells as bioreactors for the release of 2′,3′-dideoxycytidine, an inhibitor of HIV infectivity
  505. Improved stability of 2,3‐bisphosphoglycerate during storage of hexokinase‐overloaded erythrocytes
  506. Reversed-phase high-performance liquid chromatography separation of dimethylaminoazobenzene sulfonyl- and dimethylaminoazobenzene thiohydantoin-amino acid derivatives for amino acid analysis and microsequencing studies at the picomole level
  507. Effects of Ca2+ and lipoxygenase inhibitors on hexokinase degradation in rabbit reticulocytes
  508. Human Red Blood Cell Loading with Hexokinase-Inactivating Antibodies
  509. Reversed-phase liquid chromatographic determination of 2′,3′-dideoxycytidine in human blood samples
  510. Improved metabolic properties of hexokinase-overloaded human erythrocytes
  511. Hexokinase type I multiplicity in human erythrocytes
  512. Role of hexokinase in the regulation of erythrocyte hexose monophosphate pathway under oxidative stress
  513. Effect of phenylhydrazine on red blood cell metabolism
  514. Simultaneous Preparation from Human Placenta of Several Enzymes of Glucose Metabolism
  515. Superoxide anions are required for the inactivation ofEscherichia coli induced by high concentrations of hydrogen peroxide
  516. Hexokinase microheterogeneity in rabbit red blood cells and its behaviour during reticulocytes maturation
  517. Effect of age on some properties of mice erythrocytes
  518. Membrane-Bound Immunoglobulins Increase during Red Blood Cell Aging
  519. Purification, properties, and evidence for two subtypes of human placenta hexokinase type I
  520. The interaction of phosphorylated sugars with human hexokinase I
  521. Adenine and pyridine nucleotides during rabbit reticulocyte maturation and cell aging
  522. Red blood cell phagocytosis and lysis following oxidative damage by phenylhydrazine
  523. Relationships between the age-dependent decay of glucose-1,6-bisphosphate synthesis, phosphoribomutase and phosphoglucomutase in human red cells
  524. Glucose metabolism in fibroblasts from patients with erythrocyte hexokinase deficiency
  525. First trimester monitoring of a pregnancy at risk for glucose phosphate isomerase deficiency
  526. Human erythrocyte hexokinases are immunologically related
  527. Rat red blood cell hexokinase purification, properties and age-dependence
  528. Increased Erythrocyte Adenosine Deaminase Activity without Haemolytic Anaemia
  529. Redox and Energetic State of Red Blood Cells in G6PD Deficiency, Heterozygous β-Thalassemia and the Combination of Both
  530. Complete high-performance liquid chromatographic separation of 4-N,N-dimethylaminoazobenzene-4′-thiohydantoin and 4-dimethylaminoazobenzene-4′-sulphonyl chloride amino acids utilizing the same reversed-phase column at room temperature
  531. Hereditary nonspherocytic hemolytic anemia due to a new hexokinase variant with reduced stability
  532. Human erythrocyte hexokinase deficiency: a new variant with abnormal kinetic properties
  533. Hexokinase in human chorionic villi
  534. Regulatory properties of human erythrocyte hexokinase during cell ageing
  535. Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells
  536. Red blood cell adenine nucleotides abnormalities in down syndrome
  537. Hexokinase in developing rabbit erythroid cells
  538. A new direct radioassay for the determination of true erythrocyte hexokinase activity
  539. Relationship between the rate of erythrocyte hexose monophosphate pathway and the glucose 6-phosphate concentration
  540. Rabbit red blood cell hexokinase:intracellular distribution during reticulocytes maturation
  541. Regulatory properties of rabbit red blood cell hexokinase at conditions close to physiological
  542. Increased Activity of Glutathione S-Transferase and Fast Decay of Reduced Glutathione in Fanconi’s Anemia Erythrocytes
  543. Rabbit red blood cell hexokinase
  544. Red Blood Cell Hexokinase in Fanconi’s Anemia
  545. Regional Mapping of Hexokinase-1 within the Short Arm of Chromosome 10
  546. Pig red blood cell hexokinase: Evidence for the presence of hexokinase types II and III, and their purification and characterization
  547. Pig red blood cell hexokinase: Regulatory characteristics and possible physiological role
  548. Prenatal prediction of duplication 10q24→qter by gene dosage of GOT1 on uncultured amniotic cells
  549. The age-dependent metabolic decline of the red blood cell
  550. Red Blood Cell Hexokinase in Tumor Bearing Mice
  551. Red blood cell glucose metabolism in trisomy 10p: possible role of hexokinase in the erythrocyte
  552. Relationship between Erythrocyte Hexokinase in Cancer Patients and Red Cell Age
  553. Red Blood Cell Galactokinase Activity and Presenile Cataracts
  554. Regional mapping of the locus for hexokinase-1 (HK1)
  555. Molecular forms of red blood cell hexokinase
  556. Solubilization, purification, and properties of rabbit brain hexokinase
  557. Adult and fetal galactokinases in human red blood cells
  558. Chromatographic fractionation of multiple forms of red blood cell hexokinase
  559. Cell survival and glutathione reductase
  560. A New Variant of Galactokinase
  561. [1] Hexokinase from rabbit red blood cells
  562. Human Erythrocyte Galactokinase: A Population Survey
  563. Expression of GALT in two unrelated 9p- patients. Evidence for assignment of the GALT locus to the 9p21 band
  564. The possibility of prenatal diagnosis by gene dosage: Confirmation of duplication 10q24→qter from Got-l activity in fetal erythrocytes
  565. Hexokinase isozymic pattern during red cell aging
  566. Action of oxidized and reduced glutathione on rabbit red blood cell hexokinase
  567. Galactokinase activity and red blood cell age
  568. Studies on the use of Sepharose-N-Aminohexanoyl-Glucosamine for purification of rabbit red blood cell hexokinase
  569. Spectrophotometric analysis of interferences due to polyols in the assay of protein by Lowry's method
  570. Comparative studies of glucose metabolism on mammals' red blood cells
  571. Decay pattern of rabbit erythrocyte hexokinase in cell aging
  572. Comparative studies of galactokinase activity on mammal's red blood cells
  573. Confirmation of regional assignment of nucleoside phosphorylase to band 14q13 by gene-dosage studies
  574. Comparative studies on red blood cell glucose phosphorylating activities of mammals
  575. Glucokinase and Hexokinase in Pig Erythrocytes
  576. Relationship between glucose phosphorylating activities and erythrocyte age
  577. Immobilization of Enzymes and Proteins on Red Blood Cells
  578. An Ex Vivo Erythrocyte Model for Investigating Oxidative Metabolism